z-logo
open-access-imgOpen Access
Insulin resistance in metabolic syndrome depending on the occurrence of its components
Author(s) -
Marcin Gierach,
Roman Junik
Publication year - 2021
Publication title -
endokrynologia polska
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.413
H-Index - 27
eISSN - 2299-8306
pISSN - 0423-104X
DOI - 10.5603/ep.a2021.0037
Subject(s) - insulin resistance , medicine , endocrinology , metabolic syndrome , abdominal obesity , diabetes mellitus , obesity , adipose tissue , insulin
Metabolic syndrome (MetS) is described as a cluster of several commonly occurring disorders including abdominal obesity, hypertension (HT) (≥ 130/85 mm Hg), carbohydrate disorders: impaired fasting glucose or type 2 diabetes mellitus and lipids disorders such as hypertriglyceridaemia (TG), and low levels of high-density-lipoprotein cholesterol (HDL-C). Insulin resistance (IR) is defined as a glucose homoeostasis disorder involving a decreased sensitivity of muscles, adipose tissue, liver, and other body tissues to insulin, despite its normal or increased concentration in blood.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here